The 2020 American Heart Association / American College of Cardiology guidelines for the diagnosis and treatment of patients with hypertrophic cardiomyopathy: What is new?
<p>On 22 December 2020, <em>Circulation</em> published the new American College of Cardiology / American Heart Association guidelines for the diagnosis and treatment of patients with hypertrophic cardiomyopathy. The most important guidelines were those concerning pharmacological an...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Meshalkin National Medical Research Center
2021-06-01
|
Series: | Патология кровообращения и кардиохирургия |
Subjects: | |
Online Access: | http://journalmeshalkin.ru/index.php/heartjournal/article/view/1012 |
id |
doaj-ada2f2b10f2641bfab3a9625d79b88f6 |
---|---|
record_format |
Article |
spelling |
doaj-ada2f2b10f2641bfab3a9625d79b88f62021-06-30T03:06:12Zrus Meshalkin National Medical Research CenterПатология кровообращения и кардиохирургия1681-34722500-31192021-06-0125210811510.21688/1681-3472-2021-2-108-1151361The 2020 American Heart Association / American College of Cardiology guidelines for the diagnosis and treatment of patients with hypertrophic cardiomyopathy: What is new?S. A. Budagaev0A. V. Afanasyev1A. V. Bogachev-Prokophiev2A. S. Zalesov3M. A. Ovcharov4Федеральное государственное бюджетное учреждение «Национальный медицинский исследовательский центр имени академика Е.Н. Мешалкина» Министерства здравоохранения Российской Федерации, НовосибирскФедеральное государственное бюджетное учреждение «Национальный медицинский исследовательский центр имени академика Е.Н. Мешалкина» Министерства здравоохранения Российской Федерации, НовосибирскФедеральное государственное бюджетное учреждение «Национальный медицинский исследовательский центр имени академика Е.Н. Мешалкина» Министерства здравоохранения Российской Федерации, НовосибирскФедеральное государственное бюджетное учреждение «Национальный медицинский исследовательский центр имени академика Е.Н. Мешалкина» Министерства здравоохранения Российской Федерации, НовосибирскФедеральное государственное бюджетное учреждение «Национальный медицинский исследовательский центр имени академика Е.Н. Мешалкина» Министерства здравоохранения Российской Федерации, Новосибирск<p>On 22 December 2020, <em>Circulation</em> published the new American College of Cardiology / American Heart Association guidelines for the diagnosis and treatment of patients with hypertrophic cardiomyopathy. The most important guidelines were those concerning pharmacological and invasive methods of treating symptomatic patients with obstruction of the left ventricular outlet. Considering the most recent clinical studies, the indications for invasive methods of treatment have expanded to include septal myectomy and alcohol septal ablation. A separate section in the guidelines has been devoted to the management of non-obstructive hypertrophic cardiomyopathy with preserved left ventricular ejection fraction. The recommendations for patients with hypertrophic cardiomyopathy with atrial fibrillation, ventricular arrhythmias and severe heart failure have been revised.</p><p>Received 26 March 2021. Revised 12 May 2021. Accepted 13 May 2021.</p><p><strong>Funding:</strong> The study did not have sponsorship.</p><p><strong>Conflict of interest:</strong> Authors declare no conflict of interest.</p><p><strong>Author contributions</strong><br />Conception and study design: S.A. Budagaev, A.V. Afanasyev, A.V. Bogachev-Prokophiev<br />Data collection and analysis: S.A. Budagaev, M.A. Ovcharov<br />Drafting the article: S.A. Budagaev, A.V. Afanasyev, A.S. Zalesov<br />Critical revision of the article: A.V. Bogachev-Prokophiev<br />Final approval of the version to be published: S.A. Budagaev, A.V. Afanasyev, A.V. Bogachev-Prokophiev, A.S. Zalesov, <br />M.A. Ovcharov</p>http://journalmeshalkin.ru/index.php/heartjournal/article/view/1012гипертрофическая кардиомиопатияклинические рекомендации |
collection |
DOAJ |
language |
Russian |
format |
Article |
sources |
DOAJ |
author |
S. A. Budagaev A. V. Afanasyev A. V. Bogachev-Prokophiev A. S. Zalesov M. A. Ovcharov |
spellingShingle |
S. A. Budagaev A. V. Afanasyev A. V. Bogachev-Prokophiev A. S. Zalesov M. A. Ovcharov The 2020 American Heart Association / American College of Cardiology guidelines for the diagnosis and treatment of patients with hypertrophic cardiomyopathy: What is new? Патология кровообращения и кардиохирургия гипертрофическая кардиомиопатия клинические рекомендации |
author_facet |
S. A. Budagaev A. V. Afanasyev A. V. Bogachev-Prokophiev A. S. Zalesov M. A. Ovcharov |
author_sort |
S. A. Budagaev |
title |
The 2020 American Heart Association / American College of Cardiology guidelines for the diagnosis and treatment of patients with hypertrophic cardiomyopathy: What is new? |
title_short |
The 2020 American Heart Association / American College of Cardiology guidelines for the diagnosis and treatment of patients with hypertrophic cardiomyopathy: What is new? |
title_full |
The 2020 American Heart Association / American College of Cardiology guidelines for the diagnosis and treatment of patients with hypertrophic cardiomyopathy: What is new? |
title_fullStr |
The 2020 American Heart Association / American College of Cardiology guidelines for the diagnosis and treatment of patients with hypertrophic cardiomyopathy: What is new? |
title_full_unstemmed |
The 2020 American Heart Association / American College of Cardiology guidelines for the diagnosis and treatment of patients with hypertrophic cardiomyopathy: What is new? |
title_sort |
2020 american heart association / american college of cardiology guidelines for the diagnosis and treatment of patients with hypertrophic cardiomyopathy: what is new? |
publisher |
Meshalkin National Medical Research Center |
series |
Патология кровообращения и кардиохирургия |
issn |
1681-3472 2500-3119 |
publishDate |
2021-06-01 |
description |
<p>On 22 December 2020, <em>Circulation</em> published the new American College of Cardiology / American Heart Association guidelines for the diagnosis and treatment of patients with hypertrophic cardiomyopathy. The most important guidelines were those concerning pharmacological and invasive methods of treating symptomatic patients with obstruction of the left ventricular outlet. Considering the most recent clinical studies, the indications for invasive methods of treatment have expanded to include septal myectomy and alcohol septal ablation. A separate section in the guidelines has been devoted to the management of non-obstructive hypertrophic cardiomyopathy with preserved left ventricular ejection fraction. The recommendations for patients with hypertrophic cardiomyopathy with atrial fibrillation, ventricular arrhythmias and severe heart failure have been revised.</p><p>Received 26 March 2021. Revised 12 May 2021. Accepted 13 May 2021.</p><p><strong>Funding:</strong> The study did not have sponsorship.</p><p><strong>Conflict of interest:</strong> Authors declare no conflict of interest.</p><p><strong>Author contributions</strong><br />Conception and study design: S.A. Budagaev, A.V. Afanasyev, A.V. Bogachev-Prokophiev<br />Data collection and analysis: S.A. Budagaev, M.A. Ovcharov<br />Drafting the article: S.A. Budagaev, A.V. Afanasyev, A.S. Zalesov<br />Critical revision of the article: A.V. Bogachev-Prokophiev<br />Final approval of the version to be published: S.A. Budagaev, A.V. Afanasyev, A.V. Bogachev-Prokophiev, A.S. Zalesov, <br />M.A. Ovcharov</p> |
topic |
гипертрофическая кардиомиопатия клинические рекомендации |
url |
http://journalmeshalkin.ru/index.php/heartjournal/article/view/1012 |
work_keys_str_mv |
AT sabudagaev the2020americanheartassociationamericancollegeofcardiologyguidelinesforthediagnosisandtreatmentofpatientswithhypertrophiccardiomyopathywhatisnew AT avafanasyev the2020americanheartassociationamericancollegeofcardiologyguidelinesforthediagnosisandtreatmentofpatientswithhypertrophiccardiomyopathywhatisnew AT avbogachevprokophiev the2020americanheartassociationamericancollegeofcardiologyguidelinesforthediagnosisandtreatmentofpatientswithhypertrophiccardiomyopathywhatisnew AT aszalesov the2020americanheartassociationamericancollegeofcardiologyguidelinesforthediagnosisandtreatmentofpatientswithhypertrophiccardiomyopathywhatisnew AT maovcharov the2020americanheartassociationamericancollegeofcardiologyguidelinesforthediagnosisandtreatmentofpatientswithhypertrophiccardiomyopathywhatisnew AT sabudagaev 2020americanheartassociationamericancollegeofcardiologyguidelinesforthediagnosisandtreatmentofpatientswithhypertrophiccardiomyopathywhatisnew AT avafanasyev 2020americanheartassociationamericancollegeofcardiologyguidelinesforthediagnosisandtreatmentofpatientswithhypertrophiccardiomyopathywhatisnew AT avbogachevprokophiev 2020americanheartassociationamericancollegeofcardiologyguidelinesforthediagnosisandtreatmentofpatientswithhypertrophiccardiomyopathywhatisnew AT aszalesov 2020americanheartassociationamericancollegeofcardiologyguidelinesforthediagnosisandtreatmentofpatientswithhypertrophiccardiomyopathywhatisnew AT maovcharov 2020americanheartassociationamericancollegeofcardiologyguidelinesforthediagnosisandtreatmentofpatientswithhypertrophiccardiomyopathywhatisnew |
_version_ |
1721353657677512704 |